Monday, October 24, 2016

Pulmicort Respules


See also: Generic Pulmicort Flexhaler, Generic Pulmicort Turbuhaler


Pulmicort Respules is a brand name of budesonide, approved by the FDA in the following formulation(s):


PULMICORT RESPULES (budesonide - suspension; inhalation)



  • Manufacturer: ASTRAZENECA

    Approval date: August 8, 2000

    Strength(s): 0.25MG/2ML [AN], 0.5MG/2ML [AN], 1MG/2ML [RLD]

Has a generic version of Pulmicort Respules been approved?


A generic version of Pulmicort Respules has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Pulmicort Respules and have been approved by the FDA:


budesonide suspension; inhalation



  • Manufacturer: APOTEX

    Approval date: March 30, 2009

    Strength(s): 0.25MG/2ML [AN], 0.5MG/2ML [AN]


  • Manufacturer: TEVA PARENTERAL

    Approval date: November 18, 2008

    Strength(s): 0.25MG/2ML [AN], 0.5MG/2ML [AN]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Pulmicort Respules. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Method for treating respiratory diseases
    Patent 6,598,603
    Issued: July 29, 2003
    Inventor(s): Bertil; Andersson & Thor-Björn; Conradsson & Göran; Eriksson
    Assignee(s): Astra Aktiebolag
    The invention provides a novel method of treating respiratory diseases, e.g., pediatric asthma, in a continuing regimen with not more than one daily dose of the drug budesonide using a nebulizer.
    Patent expiration dates:

    • December 23, 2018
      ✓ 
      Patent use: ONCE DAILY TREATMENT OF ASTHMA WITH NEBULIZED BUDESONIDE


    • June 23, 2019
      ✓ 
      Pediatric exclusivity




  • Method for treating a respiratory disease
    Patent 6,899,099
    Issued: May 31, 2005
    Inventor(s): Andersson; Bertil & Conradsson; Thor-Björn & Eriksson; Göran
    Assignee(s): AstraZeneca AB
    The invention provides a novel method of treating respiratory diseases, e.g., pediatric asthma, in a continuing regimen with not more than one daily dose of the drug budesonide using a nebulizer.
    Patent expiration dates:

    • December 23, 2018
      ✓ 
      Patent use: ONCE DAILY TREATMENT OF ASTHMA WITH NEBULIZED BUDESONIDE


    • June 23, 2019
      ✓ 
      Pediatric exclusivity




  • Sterile powders, formulations, and methods for producing the same
    Patent 7,524,834
    Issued: April 28, 2009
    Inventor(s): Karlsson; Ann-Kristin & Larrivee-Elkins; Cheryl & Molin; Ove
    Assignee(s): AstraZeneca AB
    The invention provides sterile glucocorticosteroids and sterile formulations containing glucocorticosteroid and use thereof in the treatment of an allergic and/or inflammatory condition of the nose or the lungs.
    Patent expiration dates:

    • November 11, 2018
      ✓ 
      Patent use: TREATMENT OF ASTHMA (MAINTENANCE AND PROPHYLACTIC THERAPY)
      ✓ 
      Drug product


    • May 11, 2019
      ✓ 
      Pediatric exclusivity



See also...

  • Pulmicort Respules Suspension Consumer Information (Wolters Kluwer)
  • Pulmicort Respules Consumer Information (Cerner Multum)
  • Pulmicort Respules Advanced Consumer Information (Micromedex)
  • Budesonide Powder Consumer Information (Wolters Kluwer)
  • Budesonide Suspension Consumer Information (Wolters Kluwer)
  • Budesonide Sustained-Release Capsules Consumer Information (Wolters Kluwer)
  • Budesonide Consumer Information (Cerner Multum)
  • Budesonide inhalation Consumer Information (Cerner Multum)
  • Pulmicort Spacer Advanced Consumer Information (Micromedex)
  • Rhinocort Turbuhaler Advanced Consumer Information (Micromedex)
  • Budesonide Advanced Consumer Information (Micromedex)
  • Budesonide Inhalation Advanced Consumer Information (Micromedex)
  • Budesonide AHFS DI Monographs (ASHP)

No comments:

Post a Comment